Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature.

Wong, Michael K K; Jarkowski, Anthony

Wong, Michael K K; Jarkowski, Anthony.

Affiliation

Wong MK; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.

Pharmacotherapy ; 29(4): 473-8, 2009 Apr.

Article in En | MEDLINE | ID: mdl-19323623

Subject(s)

Antineoplastic Agents/adverse effects; Benzenesulfonates/therapeutic use; Carcinoma, Renal Cell/complications; Heart Failure/chemically induced; Heart Failure/drug therapy; Indoles/adverse effects; Kidney Neoplasms/complications; Protein Kinase Inhibitors/therapeutic use; Pyridines/therapeutic use; Pyrroles/adverse effects; Aged; Carcinoma, Renal Cell/drug therapy; Carcinoma, Renal Cell/secondary; Case-Control Studies; Female; Humans; Kidney Neoplasms/drug therapy; Kidney Neoplasms/pathology; Niacinamide/analogs & derivatives; Phenylurea Compounds; Sorafenib; Sunitinib

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Pyrroles / Benzenesulfonates / Carcinoma, Renal Cell / Protein Kinase Inhibitors / Heart Failure / Indoles / Kidney Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Pharmacotherapy Year: 2009 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google